CorMedix Inc. (CRMD)

CorMedix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-46.34	-29.7	-28.21	-22.03	-43.54
Depreciation & Amortization	0.07	0.08	0.06	0.13	0.07
Share-Based Compensation	5.49	4.07	5.04	2.5	2.44
Other Operating Activities	2.37	1.19	1.95	-2.57	-1.13
Operating Cash Flow	-38.41	-24.36	-21.16	-21.97	-15.05
Capital Expenditures	-0.33	-0.22	-1.43	-0.11	-0.04
Change in Investments	-16.73	-3.49	-7.71	7.54	-11.98
Investing Cash Flow	-17.06	-3.71	-9.13	7.43	-12.02
Share Issuance / Repurchase	56.12	17.9	41.76	40.1	24.03
Other Financing Activities	-0.2	-	-	-	1.77
Financing Cash Flow	55.92	17.9	41.76	40.1	25.8
Exchange Rate Effect	0	-0.01	-0.01	0.01	-0
Net Cash Flow	0.45	-10.18	11.45	25.57	-1.27
Free Cash Flow	-38.74	-24.58	-22.58	-22.08	-15.09
Free Cash Flow Margin	-	-37573.53%	-11826.24%	-9229.69%	-5326.65%
Free Cash Flow Per Share	-0.76	-0.61	-0.60	-0.77	-0.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).